Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...
  •  
Login | Create an Account

36th Psychiatric Pharmacotherapy Update • 2024


 
2024 Psychiatric Pharmacotherapy Update
The University of Texas at Austin College of Pharmacy
Thursday, Oct. 24 - Friday, Oct. 25, 2024
 
 
Join the Zoom Webinar
Day 2 | Friday, October 25, 2024
Webinar ID: 881 1317 2866
 
 
About
The 2024 Psychiatric Pharmacotherapy Update offers 14+ hours of CPE content for live and on-demand learning. Registration includes Texas State Board of Pharmacy CE requirements, clinical updates, law updates and more. This event will be held from Thursday, Oct. 24, to Friday, Oct. 25. 
Target Audience
This seminar is intended for pharmacists, psychiatrists, physicians, nurses, physician assistants, psychologists and social workers* who specialize in or have an interest in neuropsychiatric disorders and wish to enhance their awareness and knowledge of the most recent advances impacting contemporary practice.
 

*Social workers, please see the agenda to identify which sessions (*) have been designated as information that will meet your specific educational needs, and offer social work-specific continuing education credit. Please feel free to register for the entire conference if you wish to participate in the non-accredited sessions for your own professional development.

Attendance Options
Registrants have the option of joining us live in person in Austin, Texas or via live virtual broadcast. In addition to the live sessions, there will be additional on-demand content included with registration. All live presentations will be recorded and available for on-demand viewing throughout the next year. With many ways to participate, you can’t miss out.
 
For those joining us in person, visit our location page on the Psychiatric Pharmacotherapy Update website for more information.
Registering and Accessing the Content
Psychiatric Pharmacotherapy Update registrants will access all seminar content on this page. Be sure to bookmark this page for session content, live broadcast Zoom feeds and on-demand sessions. You are required to log into your account to access seminar content, so we recommend keeping your login email and password handy.
 
  Register for 2024 Psychiatric Pharmacotherapy Update
  • NOTE: If you have previously registered for the live event, skip down to Log Back In.
  • First, you must register for the activity using the GREEN button at the bottom of the page.
    • (Note: If you have never claimed CE credit through this UT Austin College of Pharmacy CE site before, you will also be prompted to create a CE profile before you can register for this program). 
  • Once you are registered & logged in, save your email & password for easier access when you return to complete additional sessions.
  • Click one of the sessions listed below and follow the instructions listed in that module.
  • If you wish to return to the program later, do so by following the instructions in the orange box below.
 
  Log Back In 
  • Bookmark this page. When you return, click on the "log in" link at the top right. (NOTE: this registration page is the same page you will use during the live event and for on-demand sessions later.)
  • Enter your email/password at the prompt.
  • Click one of the sessions listed below and follow the instructions in that module.

Date: Oct 24, 2024 07:00 AM - Oct 25, 2024 04:30 PM

Fee

$595.00

CE Hours

20.25

CE Units

2.025

Registration closes on Jul 01, 2027 01:00 AM

Activity Type

  • Knowledge

Support/Credits

Additional Event Information
  • Session content: The tabs below contain content. PDF copies of the presentation slides will be added to each session tab closer to the event day.
  • Zoom links for live broadcast: As we approach the event, Zoom links will be available below. There is one webinar link for each day. The program will broadcast a constant stream that you can leave and return to as you can. You will need to log into Zoom, but you can use a free Zoom account for this broadcast.
  • All content will be recorded: All content will be recorded for viewing online after the event – so if you miss a session, no worries. You will be able to see sessions over the next year (please allow 4 to 6 weeks for recordings to appear).
  • On-demand sessions: You can open the links below to find the on-demand videos embedded in the system. Recordings of the live sessions will be placed in the tabs in the same way.
  • Evaluations: You will be able to access and complete evaluations at the scheduled time the live session ends. If the speaker is to finish early, just know the evaluation will eventually become live at the originally scheduled time.
  • CE credit/certificate: Upon completing the online evaluations following each session. For pharmacy, the credit for that session will be automatically uploaded to the NAPB profile you entered in this system. For all other professions, you can download the certificate after completing evaluations via the "View/Print CE Cert" tab at the top of the page.
  • Thank you: We know you have options on where you get your CE. We greatly appreciate you choosing The University of Texas at Austin College of Pharmacy! Thank you!
Continuing Education Credit
The conference includes CPE, CME, NCPD, APA, and contact hours for counselors and Social Workers. See the CE Website for specific continuing credit information:  https://sites.utexas.edu/cpe-ppu/agenda/ce-credits/ (opens in new window)
Credits are awarded on a downloadable certificate upon completion of session evaluations. One must complete the evaluation for each session they attend. Session evaluations become available via a green button on each session tab when you are logged into your account. The certificates will automatically update hours completed as one completes online evaluations. If you were to complete evaluations and download the certificate yet then complete evaluations for additional sessions, you can re-download the certificate, which will update based on the evaluations completed. Registrants are not allowed to claim credit for sessions they did not attend. 
 
Certificates will remain available on this site for two years upon completion.
 
Questions?
At any time, please email us at UTpharmacyCE@austin.utexas.edu – we monitor this email daily and will be monitoring it all day during the live event.

 

 

 

 

   

Welcome to Day 1 of the 2024 Psychiatric Pharmacotherapy Update
Thursday, October 24, 2024
 
 
 
The 2024 Psychiatric Pharmacotherapy Update is held as both an in-person and live broadcast event. 
Know all content will be recorded for on-demand video learning by December.
 
Please note the icons in the session tabs below. 
 
The "in-person" icon lets you know the session is for in-person attendance at the DoubleTree
 
 
 
The "live broadcast" icon indicates that the session is available on the Zoom webinar
 
 
 
The "on-demand" icon indicates the session contains a video for viewing the content anytime
 
 
 
Please access presentation slides, evaluations, eventually on-demand videos in the tabs below
Please note, the evaluations will become live at the scheduled time the session is to end.  If it ends early, please wait for the scheduled time for it to become open.
 
Date: 10/24/24
Time: 07:00 AM - 05:00 PM
   

   

In-person — Check-in and Breakfast
 
In-person attendees can pick up their name badge and program in the registration area. 
 
All programs will be held in the DoubleTree Ballroom. The check-in area is just outside the classroom.
 
  • Breakfast for in-person attendees will be provided each morning starting at 7:30 a.m.
 
 
Date: 10/24/24
Time: 07:30 AM - 08:00 AM
   

   

Welcome and Morning Announcements
 
 
 
Date: 10/24/24
Time: 08:00 AM - 08:15 AM
   

   

Psychopharmacology Fact or Myth?
 
 
Learning Objectives 
  • Assess common misperceptions in psychopharmacology related to treating patients with serious mental illness (SMI).
  • Evaluate if available evidence supports or disproves common psychopharmacologic treatment myths.
  • Create evidence-based recommendations using case examples.  
About the Speakers
Brendon Hogan, Pharm.D., BCPP
VISN12 CRH Pharmacy Program Manager
Clinical Pharmacy Specialist – Psychiatry
Mental Health and Pain Clinical Pharmacy Practitioners
Certified BFA Instructor
Brendon Hogan obtained his B.A. in Bio-Chemistry from the University of North Texas in 2010 and his Doctorate in Pharmacy from the University of Texas at Austin in 2015. He completed a PGY1 General Pharmacy Residency in 2016 and a PGY2 in Psychiatric Pharmacy Residency in 2017 at the Central Texas Veterans Health Care System (CTVHCS) in Temple, Texas. He then began work in the outpatient mental health clinic (MHC) at CTVHCS doing medication management and using non-traditional treatment modalities such as auricular acupuncture and cranial electrotherapy stimulation. In 2018 he became Residency Program Director (RPD) for the PGY2 Psychiatric Pharmacy program and in 2019 he became a certified trainer for Battlefield Acupuncture (BFA). In December 2019 he was hired as the Clinical Pharmacy Supervisor for the Mental Health and Pain Clinical Pharmacy Practitioners (CPP). In 2024 he became the Pharmacist Program Manager for VISN12 Clinical Resource Hub.
Disclosure: Dr. Hogan does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).
 
Kristen Neumeister, Pharm.D., BCPP
Clinical Pharmacy Specialist - Psychiatry
Health and Specialty Care System | North Texas State Hospital
Texas Health and Human Services Commission
Kristen Neumeister is a board-certified psychiatric pharmacist who received her Pharm.D. degree from Drake University College of Pharmacy and completed her psychiatric residency training at the Minneapolis VA Health Care System. Following her residency training, Kristen began working at John Peter Smith Hospital in Fort Worth, TX where she was actively involved in precepting pharmacy learners and resident psychiatrists, lecturing for the psychiatry residency program, and rounding with interdisciplinary treatment teams. After 6 years at John Peter Smith Hospital, she transitioned to a new role at North Texas State Hospital, where she completes psychopharmacology consults, serves as a drug information resource, creates and updates policies and protocols, and attends multidisciplinary treatment team rounds. She is also an appointed member of the HHSC Psychiatric Executive Formulary Committee and served on the Recertification Editorial Board for the American Association of Psychiatric Pharmacists (AAPP) from 2020-2023.
Disclosure: Dr. Neumeister does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).
 
 

Activity Number

0067-0000-24-125-L01-P/T
Date: 10/24/24
Time: 08:15 AM - 09:15 AM

CE Hours

1.00
   

   

Autism and Psychiatric Disorders
 
 
Learning Objectives 
  • Describe clinical issues relating to autism spectrum disorder (ASD) and psychiatric disorders
  • Recognize important gaps in research and clinical understanding regarding the co-occurrence of ASD and other common psychiatric disorders
  • Describe key clinical issues relating to complex patient management for individuals with autism
About the Speaker
Young Shin Kim, M.D., M.S., MPH, Ph.D.
Professor
Department of Psychiatry and Behavioral Sciences
The University of Texas at Austin Dell Medical School 
Young Shin Kim, M.D., M.S., MPH, Ph.D. is Professor of Psychiatry and Associate Chair for Child and Adolescent Psychiatry at Dell Medical School. She is also the Division Chief of Child and Adolescent Psychiatry at Dell Children’s Medical Center and Executive Director of the Texas Child Mental Health Care Clinical Program. Internationally recognized, Dr. Kim specializes in developmental psychopathology including autism spectrum disorder (ASD).
Originally from Korea, Dr. Kim obtained her medical degree and completed her psychiatry residency at Yonsei College of Medicine, Seoul. She furthered her training at Yale Child Study Center, completing clinical and research fellowships in Child and Adolescent Psychiatry, alongside an MPH at Yale School of Public Health. Her career continued in Korea as Chair of Psychiatry at Hallym University Hospital, before earning her Ph.D. in epidemiology at UC Berkeley. At Yale, she advanced her autism, school bullying and genetic epidemiology research, and later, she was recruited to UCSF, founding the UCSF Center for ASD and Neurodevelopmental Disorders, integrating clinical and research efforts.
Her research, spanning epidemiology and genetic epidemiology, aims to uncover neurodevelopmental disorders' risk mechanisms. She has led extensive large-scale extensive research in Korea, the US, the Navajo Nation, Japan, and the Republic of Georgia. Dr. Kim is committed to community outreach and service, advocating for psychiatrically challenged children, adolescents, youth and their families. Her scientific and clinical contributions have been acknowledged with numerous awards, notably the Presidential Early Career Award for Scientists and Engineers (PECASE) from President Obama. 
Disclosure: Dr. Kim does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).
 

Activity Number

0067-0000-24-126-L01-P/T
Date: 10/24/24
Time: 09:15 AM - 10:15 AM

CE Hours

1.00
   

   

Refreshment Break (15 minutes)
 
 
In-person attendees: Join us for a refreshment break.
Virtual attendees: Please enjoy a quick break. 
Date: 10/24/24
Time: 10:15 AM - 10:30 AM
   

   

Evaluating Psychotropic Medications: Valuable New Agents for Patients vs. Profitable Additions for Companies?
 
Learning Objectives 
  • Discuss the obstacles to new medication development.
  • What is a therapeutic breakthrough and what is a me-too psychotropic medication?
  • Outline the role that serendipity has played in psychotropic drug development.
  • Delineate potential innovations psychotropic drug development. 
About the Speaker
M. Lynn Crismon, Pharm.D., FCCP, DABCP, BCPP
Dean Emeritus
Behrens Centennial Professor Emeritus of Pharmacy
Professor of Psychiatry and Behavioral Sciences
The University of Texas at Austin College of Pharmacy
M. Lynn Crismon is Dean Emeritus and Behrens Centennial Professor Emeritus of Pharmacy and Professor of Psychiatry & Behavioral Sciences at The University of Texas at Austin. He is board-certified in psychiatric pharmacy, and he is a Diplomate of the American Board of Clinical Pharmacology. His research has focused on strategies to improve the pharmacotherapy and health outcomes of adults and children with severe mental disorders. He is vice chair and founding steering committee member, faculty member, and coach in the REACH Institute’s Patient-Centered Mental Health in Pediatric Primary Care Mini-fellowship. He served as a member of the National Academy of Medicine Committee that developed Taking Action Against Clinician Burnout: A Systems Approach to Professional Well-Being which received the 2021 James A. Hamilton Book Award from the American College of Healthcare Executives. In 2021 he was awarded the ACCP Paul F. Parker Medal for Distinguished Service to the Profession of Pharmacy, and he is the 2024 recipient of the AACP Paul R. Dawson Award for Excellence in Patient Care Research Award.
Disclosure: Dr. Crismon does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).
 

Activity Number

0067-0000-24-127-L01-P/T
Date: 10/24/24
Time: 10:30 AM - 11:30 AM

CE Hours

1.00
   

   

Psychedelic Treatment of Mental Illness
 
 
Learning Objectives 
  • Identify factors that differentiate psychedelic-assisted therapies from other evidence-based treatment approaches
  • Discuss psilocybin-assisted psychotherapy evidence base
  • Discuss MDMA-assisted psychotherapy evidence base
  • Identify key areas for further development in optimizing and disseminating this novel approach
About the Speaker
Greg Fonzo, Ph.D.
Assistant Professor and Co-Director
Center for Psychedelic Research and Therapy
Department of Psychiatry and Behavioral Sciences
The University of Texas at Austin Dell Medical School
Greg Fonzo, Ph.D., is an Assistant Professor and Co-Director of the Center for Psychedelic Research and Therapy in the Department of Psychiatry and Behavioral Sciences at The University of Texas at Austin Dell Medical School.??He completed his Ph.D. in Clinical Psychology at the San Diego State University/University of California-San Diego Joint Doctoral Program.??He completed his postdoctoral fellowship in?bio-behavioral research at the Stanford University School of Medicine.??Dr. Fonzo’s research encompasses two main themes.??First, his laboratory utilizes non-invasive neuroscience tools such as neuroimaging and neuromodulatory probes to understand neurobiological mechanisms of stress-related mental health disorders such as posttraumatic stress disorder, anxiety, and major depression.??Second, his laboratory focuses on designing novel neuroscience-informed interventions to alleviate mental health symptoms, with a particular focus on psychedelic-assisted therapies and neuromodulation. In his clinical practice, he specializes in the assessment and evidence-based psychotherapeutic treatment of posttraumatic stress disorder, anxiety, and depression. 
Disclosure: Dr. Fonzo does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).
 

Activity Number

0067-0000-24-128-L01-P/T
Date: 10/24/24
Time: 11:30 AM - 12:45 PM

CE Hours

1.25
   

   

Lunch
Optional Continuing Professional Development Discussion
 
 
In-person attendees: Join us for lunch.
Virtual attendees: Please enjoy a lunch break. 
 
Optional Continuing Professional Development Discussion
 
This optional Continuing Professional Development Discussion involves guided reflections about topics and treatment changes based on morning topics. Participants may choose any topic from the conference presentations that are most likely to impact or improve their practice. 

Worksheet: For in-person attendees, you can pick up a worksheet at the check-in table, others may use the downloadable document. Use this document for the discussion and reflection of the chosen topic. The worksheet displays areas that have been demonstrated as the major barriers or areas that impact the implementation of new content into practice. 

Take notes as you reflect. When you go to complete the evaluations for CE credit, the evaluation will ask you to share what you wrote in the worksheet. (NOTE: simple answers will not result in credit - one must truly reflect on the topic. 

Learning Objectives 
  • Discuss the impact of key takeaways of conference topics on practice
  • Discuss practice implementation planning for conference topics
About this Program:
Literature on continuing education in healthcare has demonstrated a lack of results from learning new knowledge to the actual implementation of new knowledge into practice. The process of implementation includes several steps or barriers to the implementation of new knowledge. These include:
  • Identifying what changes in practice
  • Understanding the impact and/or need for other healthcare team members' involvement
  • Changes or updates to existing guidelines that may create barriers to implementation
  • Using tools and information from the presentation to help facilitate implementation
  • Steps of actual implementation - this may include understanding the timing and frequency of actual change
Contemplating and understanding the steps and barriers to implementation have been shown to make a significant difference in the actual implementation of new knowledge into practice. The use of this exercise on key concepts will help ensure the use of new knowledge in practice. 

Facilitator: Glen Baumgart, Ph.D. serves as Director of the Center for Continuing Professional Development at The University of Texas at Austin College of Pharmacy. He holds a doctorate in educational psychology and has extensive experience in managing education discussion sessions. Disclosure: Dr. Baumgart has no financial relationship(s) to disclose.

 

Activity Number

0067-9999-24-145-L04-P/T
Date: 10/24/24
Time: 12:45 PM - 01:45 PM

CE Hours

0.50
   

   

The Role of Ketamine and Esketamine in Practice and the Logistics of Prescribing
 
 
Learning Objectives 
  • Review the FDA-approved and evidence-supported off-label use of Ketamine and Esketamine for treatment-resistant depression and suicidality. 
  • Identify when it is recommended to implement ketamine/esketamine vs other treatment modalities for treatment-resistant depression and suicidality, including guidelines if they exist. 
  • Discuss potential barriers or warnings to patients and providers with the wide range of ketamine and esketamine options available such as telehealth supervised administration, ED, and other non-psychiatric infusion options
About the Speaker
Brent Turnipseed, M.D.
Medical Director
Roots Behavioral Health
Brent Turnipseed, M.D., is a co-founder and Medical Director of Roots Behavioral Health, a mental health clinic in Austin, Texas. He is board-certified by the American Board of Psychiatry and Neurology and a Fellow of the American Psychiatric Association. In collaboration with Dr. Phil Wolfson and the Ketamine Training Center in San Anselmo, California, Dr. Turnipseed published the first observational cohort of ketamine-assisted psychotherapy outcomes. Additionally, he served as principal investigator for NRX Pharmaceuticals’ phase II trial for NRX-101, an investigational drug for treating bipolar depression. As Roots’ Medical Director, Dr. Turnipseed is leading a novel approach to psychiatric care by utilizing the Brain Health Assessment. This tool helps patients understand contributing factors to their mental illness and how best to address them. 
Disclosure: Dr. Turnispeed does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).
 

Activity Number

0067-0000-24-129-L01-P/T
Date: 10/24/24
Time: 01:45 PM - 02:45 PM

CE Hours

1.00
   

   

Refreshment Break (15 minutes)
 
 
In-person attendees: Join us for a refreshment break.
Virtual attendees: Please enjoy a quick break. 
Date: 10/24/24
Time: 02:45 PM - 03:00 PM
   

   

Psychotropic Stewardship: Focus on Antipsychotics
 
 
Learning Objectives 
  • Define the concepts of Psychotropic Stewardship and how these can be applied to antipsychotic use.
  • Review the literature supporting the vision of psychotropic stewardship and antipsychotic medications.
  • Recommend initial steps to implement a pharmacist led psychotropic stewardship program supporting safe antipsychotic use
  • Measure the effectiveness of a psychotropic stewardship program for antipsychotics
About the Speaker
Robert Haight, Pharm.D., BCPP
Clinical Pharmacist | Forensic Services
Saint Peter Regional Treatment Center (SPRTC)
Minnesota Department of Human Services
Dr. Robert Haight earned a Doctor of Pharmacy from the University of Minnesota, College of Pharmacy in 1998 and completed a residency in Psychopharmacology Research at Regions Hospital, Saint Paul, Minnesota in 1999. Dr. Haight joined the University of Minnesota Medical Center (UMMC) in Minneapolis, Minnesota as a Clinical Pharmacy Specialist in Psychiatry in 2001. In May 2020 he joined the Minnesota Department of Human Services in Forensic Services at the Saint Peter Regional Treatment Center. He also spends 50% of his time working with patients with intellectual and developmental disabilities at the Southern Cities Clinic through Minnesota Department of Human Services, Direct Care and Treatment. Dr. Haight is the SPRTC residency coordinator for the Minnesota Direct Care and Treatment, PGY2 Psychiatric Pharmacy Residency Program. His interests include the use of shared decision-making aids, psychotropic stewardship, and improving transitions of care by utilizing psychiatric pharmacy and medication therapy management teams.
Disclosure: Dr. Haight does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).
 

Activity Number

0067-0000-24-130-L01-P/T
Date: 10/24/24
Time: 03:00 PM - 04:00 PM

CE Hours

1.00
   

   

Psychotropic New Drug Update
 
 
Learning Objectives 
  • Describe the pharmacology, adverse effects, drug interactions, therapeutic uses, and dosing of selected psychiatric drugs recently marketed as well as drugs approaching the market.
  • Review pharmacology, adverse effects, drug interactions, therapeutic uses, and dosing of selected psychiatric drugs that have been released in the past five years.
About the Speaker 
Stephen R. Saklad, Pharm.D., BCPP
Clinical Professor (Retired)
The University of Texas at Austin College of Pharmacy  
Division of Pharmacotherapy, UT Health San Antonio, Joe R. & Teresa Lozano Long School of Medicine
Pharmacotherapy Education and Research Center  
Dr. Saklad is a Clinical Professor at The University of Texas College of Pharmacy and a Pharmacist at San Antonio State Hospital since 1979. He has focused his career on clinical care, teaching, and research to improve the quality of life and function in the serious and persistently mentally ill. He helped to create a clinical research unit at San Antonio State Hospital and developed the first websites for The University of Texas College of Pharmacy and the College of Psychiatric and Neurologic Pharmacists (CPNP). He is the Director of the University of Texas Psychiatric Pharmacy Program in San Antonio, having trained over 70 advanced practice pharmacists in psychiatric pharmacy. Dr. Saklad is a Founding Member of CPNP, served on the CPNP Board of Directors and was the founding senior editor of their peer-reviewed journal, the Mental Health Clinician. He has published articles and presented to many groups around the country on a variety of pharmacy and mental health-related topics. He is a principal or co-investigator for several studies of the efficacy and adverse effects of Phase II, III, and IV psychotropic agents in schizophrenia, mood disorders, and other serious mental illnesses, as well as their pharmacokinetics and interactions. He has received several honors, most recently the Judith J. Saklad Memorial Award from CPNP in 2012 and the Teaching Excellence Award from the UT College of Pharmacy in 2013.
 
Disclosure: Dr. Stephen Saklad has the following relevant financial relationships, potential or perceived, with commercial or conflicts of interest to disclose:
Speakers Bureau: Actavis, Otsuka, Sunovion
Consultant: Janssen, Jazz, Otuska, Teva
Other: Member of Pharmacists Foundation, Business Development Council for San Antonio

Mitigation: The University of Texas at Austin College of Pharmacy event planning committees reviewed the relationships and determined there was no connection between presentations and disclosed relationships.

Review of Conflicts Policy: The UT Austin College of Pharmacy has a very strict policy to ensure against commercial conflicts of interest in CE programming. For this conference, the planning committee picks two committee members who have appropriate backgrounds to review content and report any potential conflict of interest to the CPE Director. If conflict issues are discovered, they are addressed with speakers to make appropriate changes. Evaluations are collected from all participants with specific questions around the listed conflicts of commercial interest.

 

Activity Number

0067-0000-24-131-L01-P/T
Date: 10/24/24
Time: 04:00 PM - 05:00 PM

CE Hours

1.00
   

   

Reception
 
 
 
In-person attendees: Join us for refreshments at our end-of-day reception. 
Date: 10/24/24
Time: 05:00 PM - 06:00 PM
   

 

   

Welcome to Day 2 of the 2024 Psychiatric Pharmacotherapy Update
Friday October 25, 2024
 
The 2024 Psychiatric Pharmacotherapy Update is held as both an in-person and live broadcast event. 
Know all content will be recorded for on-demand video learning by December.
 
Please note the icons in the session tabs below. 
 
The "in-person" icon lets you know the session is for in-person attendance at the DoubleTree
 
 
 
The "live broadcast" icon indicates that the session is available on the Zoom fee
 
 
 
The "on-demand" icon indicates the session contains a video for viewing the content anytime.
 
 
 
Please access presentation slides, evaluations, eventually on-demand videos in the tabs below
Please note, the evaluations will become live at the scheduled time the session is to end.  If it ends early, please wait for the scheduled time for it to become open.
 
Date: 10/25/24
Time: 07:30 AM - 05:00 PM
   

   

In-person — Check-in and Breakfast
 
In-person attendees can pick up their name badge and program in the registration area. 
 
All programs will be held in the DoubleTree Ballroom. The check-in area is just outside the classroom.
 
Breakfast for in-person attendees will be provided each morning starting at 7:30 a.m.
 
 
Date: 10/25/24
Time: 07:30 AM - 08:00 AM
   

   

Welcome and Morning Announcements
 
 
 
Date: 10/25/24
Time: 08:00 AM - 08:15 AM
   

   

Effectiveness of Non-stimulants vs Stimulants for ADHD in Children and Adults
 
Learning Objectives 
  • Review current studies of both stimulants and non stimulant in the treatment of ADHD in both children and adults.
  • Compare and contrast the efficacy and rate of adverse events in both stimulants and non-stimulants for both stimulants and non-stimulants.
  • Examine recent "Big Data" studies that address the long term risks and benefits of the pharmacological treatment of ADHD.
About the Speaker
Steven R. Pliszka, M.D.
Professor of Psychiatry
The University of Texas Health San Antonio
Steven R. Pliszka, M.D. is Professor of Psychiatry at  the University of Texas Health Science Center at San Antonio. He has been a faculty member at UT Health San Antonio since 1986, joining the Department of Psychiatry after completing his general and child adolescent psychiatry residencies at UTHSCSA. Throughout his career he has been involved in a wide range of administrative, research, clinical and educational activities. He has as Chief of the Division of Child and Adolescent Psychiatry from 1995-2015 and Chair of the Department of Psychiatry & Behavioral Sciences from 2015-2023. His research has focused on Attention Deficit Hyperactivity Disorder (ADHD) and related disorders. He has been involved with clinical trials of the most medications used for ADHD. Dr. Pliszka is the author of “Neuroscience for the Mental Health Clinician, 2nd ed.” and “Treating ADHD and Comorbid Disorders (Guilford Press). He has been very active in the American Academy of Child and Adolescent Psychiatry, authoring the academy’s practice parameters for the diagnosis and treatment of ADHD in 2007.  He currently is the Medical Director for the San Antonio branch of Texas Child Health Access Through Telemedicine (TCHATT), a state-wide program for expanding mental health treatment in schools. Dr. Pliszka serves as the attending psychiatrist for two residential facilities for children with severe behavioral and emotional disorders.
Disclosure: Dr. Pliszka does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).
 

Activity Number

0067-0000-24-132-L01-P/T
Date: 10/25/24
Time: 08:15 AM - 09:15 AM

CE Hours

1.00
   

   

Dopamine Supersensitivity
 
 
Learning Objectives 
  • Review prevalence and clinical features for dopamine supersensitivity psychosis
  • Identify risk factors of aripiprazole-related psychotic exacerbation
  • Discuss a case involving suspected dopamine supersensitivity psychosis
About the Speaker
Lisa M. Mican, Pharm.D., BCPP
Director of Pharmacy
Clinical Coordinator
Austin State Hospital
Lisa M. Mican, Pharm.D., BCPP is the Director of Pharmacy for the Austin State Hospital. She obtained her Pharm.D. from the University of Texas in 2000 and completed her psychiatric residency training at the Audie L. Murphy VA Hospital in San Antonio.  Dr. Mican is a Board-Certified Psychiatric Pharmacist and has been practicing at the Austin State Hospital since 2002.  She coordinates clinical pharmacy services for the facility including decentralized team-based care and currently serves on the child and adolescent team, with other clinical pharmacists serving on the geriatrics and adult acute care teams.  She coordinates the facility pharmacy consultation service and recently implemented a new medication education and assessment consultation service for 46C clients.  She mentors and precepts pharmacist trainees from UT Austin and Texas A&M Kingsville Colleges of Pharmacy. She received the Texas Health and Human Services Patient Care Hospital Hero Award in 2018.  Dr. Mican leads quality improvement initiatives for the department and this past year the pharmacy department, in coordination with nursing services, received a Texas Health and Human Services Quality Improvement Award for the Vaccination Program Process Improvement.  Recent presentations include “Clinical Pharmacy Services in an Inpatient Psychiatric Hospital” at the European Society of Medicine Congress Vienna, Austria and continuing education programs on Benzodiazepine Deprescribing and Use of Long-Acting Antipsychotic Injectable medications for Texas Health and Human Services.  She served as an exam item writer for the Board of Psychiatric Specialties certification exam and manuscript peer reviewer for pharmacy and psychiatry journals. 
Disclosure: Dr. Mican does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).
 

Activity Number

0067-0000-24-133-L01-P/T
Date: 10/25/24
Time: 09:15 AM - 10:15 AM

CE Hours

1.00
   

   

Date: 10/25/24
Time: 10:15 AM - 10:30 AM
   

   

Rapid Fire: Mental Health Treatment Updates
 
 
This session consists of four 15-minute sessions. All speakers will be available for a Q&A panel at the end of the presentations. 
 
Learning Objectives
Schizophrenia Update: Discussion of New Treatments – Dr. Troy A. Moore
•  Discuss new schizophrenia treatments and pipeline medications
 
Bipolar Disorder Update – Dr. Rania Kattura
•  Discuss various types and uses of the most common eye drops 
 
Alzheimer's Update: Recent Discoveries and Treatments – Dr. Arash Salardini, M.D.
•  Discuss recent updates in the treatment of Alzheimer's. 
 
Insomnia Update: Review of Melatonin – Dr. Samantha Catazano
•  Discuss the use and effectiveness of melatonin and other common agents in the treatment of insomnia
About the Speakers
Troy A. Moore, Pharm.D., M.S. Pharm., BCPP
Director, ASHP Accredited PGY-1 Pharmacy Residency Program
Clinical Pharmacy Specialist, Mental Health
Rocky Mountain Regional VA Medical Center
Troy A. Moore received his PharmD from the University of New Mexico College of Pharmacy in 2003. He subsequently attended the University of Texas at Austin College, receiving his Master of Science in Pharmacy in 2005 while completing a 2-year Psychiatric Pharmacy at the San Antonio State Hospital and the South Texas Veterans Health Care System (STVHCS). He joined the University of Texas Health Science Center at San Antonio Department of Psychiatry, Division of Schizophrenia and Related Disorders in 2005 and became Assistant Professor in 2007. He joined the STVHCS as Clinical Pharmacy Specialist in Psychiatry in 2010 where he served the Substance Abuse and Domiciliary Programs. He accepted an appointment as the PGY-1 Pharmacy Residency Program Director and Clinical Pharmacy Specialist in Mental Health at the VA Eastern Colorado Health Care System (ECHCS) in Aurora, CO in December 2018. He is currently a member of the ECHCS PTSD Clinical Team (PCT) program. He has also been on the planning committee for UT Psych Update since 2007
Disclosure: Dr. Moore has the following relevant financial relationships, potential or perceived, with commercial or conflicts of interest to disclose: Advisory Board for Aklermes
 
Rania Kattura, Pharm.D., M.S.Phr., BCPP
Clinical Psychiatric Pharmacist
Austin State Hospital
Dr. Rania Kattura received her Pharm.D. degree at The University of Texas at Austin College of Pharmacy. She completed a PGY2 in Residency Psychiatric Pharmacy in combination with a Master of Science in Pharmacy at The University of Texas at Austin and its affiliated institutions (Austin State Hospital, Seton Shoal Creek, Temple VA and City of Austin Community Clinics). She is board certified in psychiatric pharmacy. Currently, Dr. Kattura is a Clinical Pharmacist at the Austin State Hospital. As a clinical pharmacist, she participates in direct patient care as a member of a multidisciplinary treatment team, provides weekly medication education groups and completes psychopharmacology consults when requested by the physicians at the hospital. The patient population she works with suffers from a variety of psychiatric disorders such as depression, schizophrenia and bipolar disorder. In addition to her patient care responsibilities, Dr. Kattura staffs in the ASH pharmacy and precepts Pharm.D. students on rotation. Dr. Kattura ensures to attend the UT Psych Update annually and has been a member of its planning committee for many years.
Disclosure: Dr. Kattura does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).
 
Arash Salardini, M.D.
Biggs Institute for Alzheimer’s & Neurodegenerative Disease 
Please check back later for this speaker's bio.
Disclosure: Dr. Salardini does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).
 
 
Samantha Catanzano, Pharm.D., BCPP
Clinical Assistant Professor of Pharmacy Practice
The University of Texas at Austin College of Pharmacy
After graduating with her Pharm.D. degree from the University of Texas at Austin, Dr. Catanzano completed a pharmacy practice residency followed by a psychiatric pharmacy practice residency at Seton Healthcare Family and The University of Texas at Austin College of Pharmacy. Following her residency training, she gained experience as a clinical and staff pharmacist at the Austin State Hospital. Currently, she serves as a Clinical Assistant Professor for The University of Texas at Austin College of Pharmacy. She also provides academic lectures to first- and second-year psychiatry residents and addiction medicine fellows through Dell Medical School’s Department of Psychiatry. In addition to her academic appointment, she is a Psychiatric Pharmacist at UT Health Austin within the Integrated Behavioral Health Department where she serves the Primary Care, Musculoskeletal, Post-COVID-19 Program, and Multiple Sclerosis clinics. In this role, she functions as part of a multidisciplinary team to address complex pharmacology and mental health needs in the community setting. Additionally, she is a certified Mental Health First Aid instructor and is an active leader within the American Association of Psychiatric Pharmacists (AAPP).
Disclosure: Dr. Catanzano does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).
 
 
 

Activity Number

0067-0000-24-134-L01-P/T
Date: 10/25/24
Time: 10:30 AM - 12:00 PM

CE Hours

1.50
   

   

Lunch
Optional Continuing Professional Development Discussion
 
 
In-person attendees: Join us for lunch.
Virtual attendees: Please enjoy a lunch break. 
 
Optional Continuing Professional Development Discussion
 
This optional Continuing Professional Development Discussion involves guided reflections about topics and treatment changes based on morning topics. Participants may choose any topic from the conference presentations that are most likely to impact or improve their practice. 

Worksheet: For in-person attendees, you can pick up a worksheet at the check-in table, others may use the downloadable document. Use this document for the discussion and reflection on the chosen topic. The worksheet displays areas that have been demonstrated as the major barriers or areas that impact the implementation of new content into practice. 

Take notes as you reflect. When you go to complete the evaluations for CE credit, the evaluation will ask you to share what you wrote in the worksheet. (NOTE: simple answers will not result in credit - one must truly reflect on the topic. 

Learning Objectives 
  • Discuss the impact of key takeaways of conference topics on practice
  • Discuss practice implementation planning for conference topics
About this Program:
Literature on continuing education in healthcare has demonstrated a lack of results from learning new knowledge to the actual implementation of new knowledge into practice. The process of implementation includes several steps or barriers to the implementation of new knowledge. These include:
  • Identifying what changes in practice
  • Understanding the impact and/or need for other healthcare team members' involvement
  • Changes or updates to existing guidelines that may create barriers to implementation
  • Using tools and information from the presentation to help facilitate implementation
  • Steps of actual implementation - this may include understanding the timing and frequency of actual change
Contemplating and understanding the steps and barriers to implementation have been shown to make a significant difference in the actual implementation of new knowledge into practice. The use of this exercise on key concepts will help ensure the use of new knowledge in practice. 

Facilitator: Glen Baumgart, Ph.D. serves as Director of the Center for Continuing Professional Development at The University of Texas at Austin College of Pharmacy. He holds a doctorate in educational psychology and has extensive experience in managing education discussion sessions. Disclosure: Dr. Baumgart has no financial relationship(s) to disclose.

 

Activity Number

0067-9999-24-146-L04-P/T
Date: 10/25/24
Time: 12:00 PM - 01:00 PM

CE Hours

0.50
   

   

Long-Acting Injectable Antipsychotic Update
 
 
Learning Objectives 
  • Discuss information resources for the newly released LAIs and how they differ.
  • Describe accessible location for LAI administration and pharmacists need to have appropriate locations for administration and knowledge of to prepare and administer each of the different LAIs.
  • Improve communication with the healthcare team members, patients, and families/caregivers to improve adherence and handle the expected requests to return to oral medication. 
About the Speaker 
Stephen R. Saklad, Pharm.D., BCPP
Clinical Professor (Retired)
The University of Texas at Austin College of Pharmacy  
Division of Pharmacotherapy, UT Health San Antonio, Joe R. & Teresa Lozano Long School of Medicine
Pharmacotherapy Education and Research Center  
Dr. Saklad is a Clinical Professor at The University of Texas College of Pharmacy and a Pharmacist at San Antonio State Hospital since 1979. He has focused his career on clinical care, teaching, and research to improve the quality of life and function in the serious and persistently mentally ill. He helped to create a clinical research unit at San Antonio State Hospital and developed the first websites for The University of Texas College of Pharmacy and the College of Psychiatric and Neurologic Pharmacists (CPNP). He is the Director of the University of Texas Psychiatric Pharmacy Program in San Antonio, having trained over 70 advanced practice pharmacists in psychiatric pharmacy. Dr. Saklad is a Founding Member of CPNP, served on the CPNP Board of Directors and was the founding senior editor of their peer-reviewed journal, the Mental Health Clinician. He has published articles and presented to many groups around the country on a variety of pharmacy and mental health-related topics. He is a principal or co-investigator for several studies of the efficacy and adverse effects of Phase II, III, and IV psychotropic agents in schizophrenia, mood disorders, and other serious mental illnesses, as well as their pharmacokinetics and interactions. He has received several honors, most recently the Judith J. Saklad Memorial Award from CPNP in 2012 and the Teaching Excellence Award from the UT College of Pharmacy in 2013.
 
Disclosure: Dr. Stephen Saklad has the following relevant financial relationships, potential or perceived, with commercial or conflicts of interest to disclose:
Speakers Bureau: Actavis, Otsuka, Sunovion
Consultant: Janssen, Jazz, Otuska, Teva
Other: Member of Pharmacists Foundation, Business Development Council for San Antonio

Mitigation: The University of Texas at Austin College of Pharmacy event planning committees reviewed the relationships and determined there was no connection between presentations and disclosed relationships.

Review of Conflicts Policy: The UT Austin College of Pharmacy has a very strict policy to ensure against commercial conflicts of interest in CE programming. For this conference, the planning committee picks two committee members who have appropriate backgrounds to review content and report any potential conflict of interest to the CPE Director. If conflict issues are discovered, they are addressed with speakers to make appropriate changes. Evaluations are collected from all participants with specific questions around the listed conflicts of commercial interest.

 

Activity Number

0067-0000-24-135-L01-P/T
Date: 10/25/24
Time: 01:00 PM - 02:00 PM

CE Hours

1.00
   

   

Refreshment Break (15 minutes)
 
 
In-person attendees: Join us for a refreshment break.
Virtual attendees: Please enjoy a quick break. 
Date: 10/25/24
Time: 02:00 PM - 02:15 PM
   

   

Pharmacotherapy of Disruptive Behavior Disorders in Youth
 
 
Learning Objectives 
  • Discuss the mental disorders associated with aggression in youth
  • Indicate the appropriate assessment of aggression in youth
  • Outline pharmacotherapy options for the treatment of aggression in youth
About the Speaker
M. Lynn Crismon, Pharm.D., FCCP, DABCP, BCPP
Dean Emeritus
Behrens Centennial Professor Emeritus of Pharmacy
Professor of Psychiatry and Behavioral Sciences
The University of Texas at Austin College of Pharmacy
M. Lynn Crismon is Dean Emeritus and Behrens Centennial Professor Emeritus of Pharmacy and Professor of Psychiatry & Behavioral Sciences at The University of Texas at Austin. He is board-certified in psychiatric pharmacy, and he is a Diplomate of the American Board of Clinical Pharmacology. His research has focused on strategies to improve the pharmacotherapy and health outcomes of adults and children with severe mental disorders. He is vice chair and founding steering committee member, faculty member, and coach in the REACH Institute’s Patient-Centered Mental Health in Pediatric Primary Care Mini-fellowship. He served as a member of the National Academy of Medicine Committee that developed Taking Action Against Clinician Burnout: A Systems Approach to Professional Well-Being which received the 2021 James A. Hamilton Book Award from the American College of Healthcare Executives. In 2021 he was awarded the ACCP Paul F. Parker Medal for Distinguished Service to the Profession of Pharmacy, and he is the 2024 recipient of the AACP Paul R. Dawson Award for Excellence in Patient Care Research Award.
Disclosure: Dr. Crismon does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).
 

Activity Number

0067-0000-24-136-L01-P/T
Date: 10/25/24
Time: 02:15 PM - 03:15 PM

CE Hours

1.00
   

   

TEACH OUD: Texans Expanding Access to Compassionate Healthcare for Opioid Use Disorder
 
 
Learning Objectives 
  • Recognize the individual and societal impacts of opioid use and opioid use disorder (OUD) with an emphasis on Texas.
  • Discuss evidence-based practices and effective treatment planning
  • Demonstrate person-centered, ethical approaches to patient care and patient communication.
  • Identify opportunities to implement evidence-based practices in the primary care setting.
About the Speaker
Daniel Sledge, B.A., L.P.
Academic Detailer
PhARM Program
The University of Texas at Austin College of Pharmacy
Daniel is a licensed paramedic and the Academic Detailer for the TEACH OUD initiative. He earned his paramedic certification from Temple College and has more than 15 years of experience in the field, including serving as the Lead Paramedic for the Williamson County Mobile Outreach Unit and the Paramedic and Medical Provider Supervisor for the newly formed Round Rock Fire Department Crisis Response Unit. Daniel responded to behavioral health crisis calls in the field in his previous roles, aiding in pre-arrest jail and emergency department diversions where possible. He also conducted follow-up visits for people who received EMS treatment for drug overdoses. During these visits, Daniel provided naloxone kits, trained patients and their loved ones on its administration, and - if wanted - helped connect them to community support and evidence-based care to reduce harm and promote positive change. Daniel is appointed to two federal committees: the SAMHSA Interdepartmental Substance Use Disorders Coordinating Committee (ISUDCC) and the National Academy of Medicine’s Action Collaborative on Countering the U.S. Opioid Epidemic. Daniel is also the 2023 recipient of the Ulysses “Mac” McLester Champion of Recovery Award by Communities for Recovery. He provides professional presentations and training on local, regional, and national levels but prefers and enjoys teaching. Before venturing into the medical field, Daniel worked as a musician and earned a Bachelor of Arts in Music from the University of North Texas. He lives with his wife, son, and two cats in Austin, TX, and his favorite food is spaghetti. 
Disclosure: Daniel Sledge does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).
 
 

Activity Number

0067-0000-24-137-L08-P/T
Date: 10/25/24
Time: 03:15 PM - 04:15 PM

CE Hours

1.00
   

   

Thank you for attending the 2024 Psychiatric Pharmacotherapy Update!
 
Date: 10/25/24
Time: 04:15 PM - 05:00 PM
   

   

Overall Evaluation • The 36th Annual Psychiatric Pharmacotherapy Update Adjourns
 
Thank you for joining us for the 36th Annual Psychiatric Pharmacotherapy Update! 
Please complete one more evaluation — the overall evaluation! Please take the time to provide feedback on the event. Based on your responses, we will pick content for next year's conference. 
 
Thank you for attending!
 
 
Date: 10/25/24
Time: 02:00 PM - 02:00 PM
   

   

On-Demand: Assessment and Management of Anxiety Disorders Among Older Adults 
 
Learning Objectives 
  • Discuss the epidemiology of anxiety disorders among older adults
  • Describe the assessment of anxiety disorders among older adults
  • Enumerate the evidence-based treatments for anxiety disorders among older adults
About the Speaker
Rajesh Tampi,.D., M.S., DFAPA, DFAAGP 
Professor and Chairman
Department of Psychiatry Creighton University
Dr. Tampi is the Professor (Tenured) and Chairman of the Department of Psychiatry, Inaugural Bhatia Family Endowed Chair in Psychiatry at Creighton University School of Medicine and Catholic Health Initiatives (CHI) Health Behavioral Health Services in Omaha, Nebraska. Dr. Tampi is also a Professor (Adjunct) of Psychiatry at Yale School of Medicine in New Haven, Connecticut. Dr. Tampi is the inaugural Historian of the American Association for Geriatric Psychiatry (AAGP). He is also a Past President of the AAGP. Dr. Tampi is a recipient of the Geriatric Academic Career Award (GACA) instituted by the Department of Health and Human Services (DHHS). He was a recipient of the AAGP’s ‘Clinician of the Year Award’ in 2013. Dr. Tampi also received the AAGP’s ‘Recognition and Appreciation’ Certificate in 2018. In 2019, he received the AAGP’s ‘Educator of the Year Award’. Dr. Tampi received the ‘2019 Outstanding Academician of the Year Award’ given by the Indo-American Psychiatric Association (IAPA). He is the recipient of the 2021 ‘Jack Weinberg Award’ for Geriatric Psychiatry given by the APA. Dr. Tampi has been honored with the 2022 ‘George Tarjan Award’ by the APA. Dr. Tampi has over 200 publications on various topics in Psychiatry and Geriatric Psychiatry. In addition, he is the Editor of 10 books in Psychiatry and Geriatric Psychiatry. Dr. Tampi serves as an Editor-in-Chief of the World Journal of Psychiatry. He is also a Triage Editor for International Psychogeriatrics, an Associate Editor for Drugs in Context (Psychiatry), an Associate Editor for the Aging Psychiatry Section of Frontiers in Psychiatry and the Section Editor of Geriatric Psychiatry for Psychiatric Times.
Disclosure: Dr. Rajesh Tampi does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).
 

Activity Number

0067-0000-24-138-H01-P/T

Release Date: Oct 23, 2024
Credit Expiration Date: Oct 23, 2027

   

   

Understanding Drug Interactions in Mental Health
 
Learning Objectives 
  • Describe the three major mechanisms of drug-drug interactions
  • Explain why understanding drug-drug interactions and clearly explaining them to patients are critical for the safe use of medications
  • List three clinically important drug-drug interactions that impact medications you see in your routine practice
About the Speaker
Stephen Saklad, Pharm.D., BCPP
Director, Psychiatric Pharmacy Program, Clinical Professor
The University of Texas at Austin College of Pharmacy
Dr. Saklad is a Clinical Professor at The University of Texas College of Pharmacy and a Pharmacist at San Antonio State Hospital since 1979. He has focused his career on clinical care, teaching, and research to improve the quality of life and function in the serious and persistently mentally ill. He helped to create a clinical research unit at San Antonio State Hospital and developed the first websites for The University of Texas College of Pharmacy and the College of Psychiatric and Neurologic Pharmacists (CPNP). He is the Director of the University of Texas Psychiatric Pharmacy Program in San Antonio, having trained over 70 advanced practice pharmacists in psychiatric pharmacy. Dr. Saklad is a Founding Member of CPNP, served on the CPNP Board of Directors and was the founding senior editor of their peer-reviewed journal, the Mental Health Clinician. He has published articles and presented to many groups around the country on a variety of pharmacy and mental health-related topics. He is a principal or co-investigator for several studies of the efficacy and adverse effects of Phase II, III, and IV psychotropic agents in schizophrenia, mood disorders, and other serious mental illnesses, as well as their pharmacokinetics and interactions. He has received several honors, most recently the Judith J. Saklad Memorial Award from CPNP in 2012 and the Teaching Excellence Award from the UT College of Pharmacy in 2013.
Disclosure: Dr. Stephen Saklad has the following relevant financial relationships, potential or perceived, with commercial or conflicts of interest to disclose:
Speakers Bureau: Actavis, Otsuka, Sunovion
Consultant: Janssen, Jazz, Otuska, Teva
Other: Member of Pharmacists Foundation, Business Development Council for San Antonio
 
 

Activity Number

0067-0000-24-119-H01-P/T

Release Date: Sep 8, 2024
Credit Expiration Date: Sep 1, 2027

CE Hours

1.00
   

   

Evidence-Based Practice for the Busy Clinician: Finding & Utilizing Guidelines to Optimize Patient Care
 
Learning Objectives 
  • Identify strategies to locate & navigate patient care guidelines.
  • Review recent guideline updates for common chronic conditions.
  • Create a personal development plan for staying up to date with guidelines in practice.
About the Speaker
Kristin Janzen, Pharm.D., BCPS
Clinical Assistant Professor
The University of Texas at Austin College of Pharmacy  
Kristin Janzen is a Clinical Assistant Professor at the University of Texas at Austin College of Pharmacy. After graduating from UT College of Pharmacy, she completed a combined PGY1 & 2 Pharmacotherapy residency at Butler University and Indiana University Health in Indianapolis, IN. She currently practices at Dell Seton Medical Center at the University of Texas in Internal Medicine, where she precepts fourth-year PharmD students and pharmacy residents on academic internal medicine rotations. She teaches throughout the didactic curriculum at the UT College of Pharmacy, focusing on pharmacotherapeutics, clinical pharmacokinetics, and application-based pharmacy practice labs. She has been recognized for both didactic and experiential teaching and has been awarded the UT Austin College of Pharmacy Educator of the Year, the Austin-Temple-Waco Region Preceptor of the Year, and Wm. Arlyn Koesel Preceptor of the Year Awards. She has also been recognized by the UT Center of Health Interprofessional Practice and Education (IPE) as a Health IPE Fellow. Her research and teaching interests focus on student preparedness for residency, interprofessional education, and core medicine disease states, such as pulmonology, cardiology, and diabetes. 
Disclosure: Dr. Janzen does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).
 

Activity Number

0067-0000-24-093-H05-P/T

Release Date: Sep 7, 2024
Credit Expiration Date: Sep 6, 2027

CE Hours

1.00
   

   

Focus on Medication Safety: Review of Real-Life Case Based Approaches
 
Learning Objectives 
  • Identify Institute for Safe Medication Practices (ISMP) Targeted Medication Safety Best Practices for Hospitals
  • Understand operational considerations related to ISMP Targeted Medication Safety Best Practices implementation in the hospital setting
  • Evaluate the impact to patient safety of ISMP-targeted medication Safety Best Practices adoption
About the Speakers
Justin Hooper, Pharm.D., BCPS - Moderator
Director, Corporate Clinical Pharmacy
Clinical Excellence Division, CHRISTUS Health
Dr. Justin Hooper graduated from the University of Texas at Austin College of Pharmacy with a Doctor of Pharmacy degree, and later completed a two-year specialty residency in pharmacotherapy with Texas Tech University Health Sciences Center at the Dallas VA Medical Center. After serving on faculty with Texas Tech University School of Pharmacy, Justin returned to his hometown of Tyler to practice pharmacy at CHRISTUS Trinity Mother Frances Health System. While at Trinity Mother Frances, he served in various capacities from staff pharmacist to director of pharmacy. Justin is now Director of Corporate Clinical Pharmacy for CHRISTUS Health, where he provides clinical pharmacy guidance and support for over 300 pharmacists across the CHRISTUS organization from New Mexico to Louisiana. His professional interests include teaching, pharmacy management and quality improvement, and clinical pharmacy informatics. Justin precepts a non-patient care P4 elective rotation and has served as a pharmacy mentor to numerous students and residents for the past ten years. Justin and his wife, Kate, live in Tyler, TX, with their four sons, and are excited to have their oldest son on the UT campus this fall. 
Disclosure: Dr. Hooper does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).
 
Panel
Tina Collins, Pharm.D.
Director, Corporate Medication Safety
Clinical Excellence Division
CHRISTUS® Health
Tina M. Collins, Pharm.D., is the Corporate Director of Medication Safety, Division of Clinical Excellence, at CHRISTUS Health. She has over 18 years of experience in healthcare and graduated from the University of Louisiana at Monroe (ULM) College of Pharmacy in 2005. She has worn many hats inside the Pharmacy department (NICU Pharmacist, Supervisor, Medication Safety Pharmacist) and beyond (Patient Safety Officer). She is responsible for coaching, guiding, leading, and mentoring Pharmacy leaders to optimize patient care delivery, medication safety, and pharmacy practice.
Disclosure: Dr. Collins does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).
 
Rukhsar Banu, Pharm.D.
Medication Safety Officer
Department of Pharmacotherapy and Pharmacy Services
University Health
I am Rukhsar Banu, a dedicated pharmacist passionate about Medication Safety. My journey started in India and continued in the United States, where I honed my skills and knowledge in pharmacy. With 17 years of diverse experience in roles such as pharmacy technician, inventory specialist, intern, and pharmacist, I have consistently contributed to projects focused on medication safety. For example, I reviewed medication errors, supported process improvement, established policies, procedures, and protocols for safe medication use, and implemented the Institute for Safe Medication Practices Best Practices. I firmly believe in the power of simplicity to drive positive outcomes. This belief has guided my commitment to excellence and innovation in every project I undertake. My work has not only contributed to my personal and professional growth but has also made a positive impact on our institution. When I'm not working, I enjoy spending quality time with my family, reading, and exploring new destinations. These activities fuel my creativity and contribute to a balanced life, which enhances my professional endeavors. Looking forward, I am excited to embrace new challenges and opportunities in the realm of medication safety. I am eager to collaborate with like-minded professionals and contribute to impactful projects that genuinely make a difference.
Disclosure: Dr. Banu does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).
 
Edward Vaughn, Pharm.D., BCPS
Director of Pharmacy, Pharmacy Department
St. David’s Round Rock Medical Center
Edward Vaughn, Pharm.D., BCPS, is the Director of Pharmacy at St. David’s Round Rock Medical Center located in Round Rock Texas. Dr. Vaughn received his Pharm.D. degree from The Texas A&M University College of Pharmacy in Kingsville, Texas. He completed a Pharmacy Practice Residency at Baylor University Medical Center in Dallas, Texas. He has also served in numerous roles including Inpatient Clinical Pharmacist, Operations Pharmacy Manager, Clinical Pharmacy Manager and Director of Pharmacy.
Disclosure: Dr. Vaughn does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).
 
Ali-Reza Shah-Mohammadi, Pharm.D., M.S., FISMP, CMQ
Medication Safety Consultant
Patient Safety
The University of Texas MD Anderson Cancer Center
Ali-Reza Shah-Mohammadi, PharmD, MS, FISMP, CMQ, received his Bachelor of Sciences degree inBiochemistry and Biology along with a Bachelor of Arts degree in Chemistry from The University of Texas at Austin. Dr. Shah-Mohammadi attended the University of Houston College of Pharmacy (UHCOP) where he received his Doctor of Pharmacy degree in 2010. Afterwards, he completed a 2-year combined MS/Residency in Health-System Pharmacy Administration at the Harris Health System (formerly Harris County Hospital District) and UHCOP in 2012. He continued his training with a fellowship focusing on safe medication management at the Institute for Safe Medication Practices (ISMP) located in Horsham, PA. Currently, he is a Medication Safety Consultant at The University of Texas MD Anderson Cancer Center in Houston, TX. In his current position, he works alongside a multidisciplinary team conducting root causes analyses; developing and leading implementation of error prevention strategies; ensuring compliance with state and federal regulatory and legal requirements relating to medication safety; building a culture of safety; influencing practice change through collaboration with other disciplines; and developing effective methods for spreading best practices throughout the organization. In addition to the responsibilities above, Dr. Shah-Mohammadi precepts both student pharmacists and pharmacy residents. He has served in different capacities as a member of the Gulf Coast Society of Health-System Pharmacists (GCSHP), the Texas Society of Health-System Pharmacists (TSHP), and the American Society of Health-System Pharmacists (ASHP). He was a past board member and Director for the GCSHP and served as a co-chair within the Texas Medical Center Residency Council. He currently serves as a member of the Board of Alumni for The Houston Program.
Disclosure: Dr. Shah-Mohammadi does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).
 

Activity Number

0067-0000-24-112-H01-P/T

Release Date: Jun 22, 2023
Credit Expiration Date: Jun 22, 2027

CE Hours

1.00
   

   

Enhancing Pediatric Medication Management in In-Patient Settings
 
Learning Objectives 
  • Apply evidence-based dosing guidelines for pediatric patients.
  • Analyze and mitigate safety risks in pediatric medication management.
  • Execute safe medication administration protocols for complex care pediatric patients.
  • Adapt communication strategies for pediatric patients and families, considering diverse needs. 
About the Speakers
Sarah Kubes, Pharm.D., BCPPS
Clinical Assistant Professor of Pharmacotherapy
The University of Texas at Austin College of Pharmacy
Dr. Kubes was born and raised in Houston, Texas. She graduated from Texas A&M University in 2006 with a BS in Biomedical Sciences, then attended the University of Houston College of Pharmacy and graduated in 2011. Dr. Kubes continued her post-graduate education as a PGY resident at Memorial Hermann Hospital in the Houston Medical Center and then a PGY2 pediatrics residency at Children’s Memorial Hermann Hospital. Following residency, she accepted a position as a Pediatric Critical Care Clinical Specialist at Cincinnati Children’s Hospital. In 2014, she re-located to San Antonio and took on the role of the Pediatric Infectious Diseases and Antimicrobial Stewardship Pharmacist at The Children’s Hospital of San Antonio. Dr. Kubes joined the UT group in 2018 as a Clinical Assistant Professor in the Pharmacotherapy Division of the College of Pharmacy at The University of Texas at Austin, as well as an Adjoint Assistant Professor in the School of Medicine and The Department of Pediatrics at the University of Texas Health Science Center at San Antonio. In addition to her teaching and research responsibilities within the college, Dr. Kubes is also responsible for clinical pharmacy services and caring for pediatric patients within the University Health System in San Antonio. Dr. Kubes also sits on the CTSHP board as a senior board member, has been appointed by the Texas Attorney General’s office and the Texas Health and Human Services commission as a Texas Medicaid Drug Utilization Review Board Member, serves as the Chair for the UT affiliated Residency Programs and vice chair for the general pediatrics special interest group for the Pediatric Pharmacy Association national organization. Her primary areas of research include quality improvement in pediatrics, cystic fibrosis and infectious diseases. Her clinical interests include pediatrics, infectious diseases and maternal health. In her spare time she is a mom to 3 children, an avid gardener, baker, reader and chicken/turkey/pheasant/duck/quail/bunny/piggy tender. 
Disclosure: Dr. Kubes does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).
 
Jenna Summerlin, Pharm.D.
Clinical Assistant Professor of Pharmacy Practice
The University of Texas at Austin College of Pharmacy
Dr. Jenna Summerlin received her Doctor of Pharmacy degree from Union University College of. Pharmacy in Jackson, Tennessee in 2020. She completed a PGY-1 Pharmacy Residency at Methodist University Hospital in Memphis, Tennessee, followed by a PGY-2 Pediatric Pharmacy Residency at Johns Hopkins All Children's Hospital in St. Petersburg, Florida. In July 2022, she joined the faculty at The University of Texas at Austin College of Pharmacy as a Clinical Assistant Professor in the Division of Pharmacy Practice. Dr. Summerlin is a board-certified pediatric pharmacist and maintains a clinical practice site at Dell Children’s Medical Center in pediatric internal medicine where she serves as a clinical pharmacy specialist and precepts residents and fourth-year Pharm.D. students. At the college, she provides didactic lectures, lab facilitation, and structured mentoring throughout the Pharm.D. curriculum. 
Disclosure: Dr. Summerlin does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).
 
 

Activity Number

0067-0000-24-102-H01-P/T

Release Date: Jun 21, 2023
Credit Expiration Date: Jun 20, 2027

CE Hours

1.00
   

   

Human Trafficking Prevention: Identifying and Responding to Victims of Human Trafficking for Pharmacists & Pharmacy Technicians
 
Learning Objectives 
  • Describe different types of human trafficking and their local, statewide and international prevalence.
  • Identify potential signs of human trafficking in victims who present for care in a medical setting.
  • Discuss the immediate healthcare needs of identified victims and develop ability for trauma-informed response.
  • Describe available resources for victims’ service and aftercare.
About the Speaker
Kerri Taylor, M.S., ccc-slp
Executive Director at Unbound Houston
Kerri Taylor is the Executive Director of Unbound Now Houston, the local chapter of Unbound Now, an international anti-human trafficking organization which focuses on domestic minor sex trafficking with specific emphasis on prevention efforts with at-risk youth. Unbound works to activate the community to fight human trafficking and is dedicated to public awareness, prevention education, professional training, and survivor advocacy.
Kerri serves on the board of the Brazoria County United Front Coalition to Fight Human Trafficking. In addition to being a member of the Child Sex Trafficking Advisory Council of Harris County, she works closely with the No Trafficking Zone, which was established in 2020, and with NRG stadium. Unbound Now Houston’s advocates are onsite at every Texans home footbal game, providing services for identified victims. In addition, she serves alongside other advocates in Galveston and Brazoria County as a coordinated response protocol for identified victims of human trafficking is developed.
Disclosure: Kerri Taylor does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).
 
 

Activity Number

0067-0000-24-121-H05-P/T

Release Date: Sep 8, 2024
Credit Expiration Date: Sep 7, 2027

CE Hours

1.50
   

   

Exhibitor - Teva
 
Thank you for visiting the Teva Medical Affairs page. The primary role of the Teva Medical Affairs organization is to educate and communicate scientific information and generate new data. Our field medical teams, consisting of Medical Science Liaisons (MSLs) and Value, Evidence, and Outcomes Liaisons (VEOs), focus particularly on specific therapeutic areas – psychiatry and movement disorders. MSLs serve as a non-promotional, objective, scientific resource both internally and externally for the company. They engage with a variety of healthcare providers (HCPs) through different activities, including presentations, one-on-ones, and conferences, allowing for a two-way flow of information between the HCP and the company. VEOs focus on communicating a product’s value proposition and health outcomes data to payers. To submit a request to meet with your MSL or VEO, please visit the Medical Personnel Request Form (tevapharm.com).
Contact Information of the MSL on site:
Sana Qureshi, Pharm.D., BCPS
Medical Science Liaison
 
TITLE CONTENT OVERVIEW LINK
Tevamedical website Information and links to various medical resources Medical Affairs (tevamedical.com)
Living-with-TD Website Information about the caregiver and patient burden of living with TD https://living-with-td.com
IMPACT-TD website
Information about the IMPACT-TD scale and patient videos showcasing the domains impacted
Medical Information Request Form Form to input unsolicited medical information requests
 
 
 

   

   

Exhibitor - Boehringer Ingelheim Virtual Booth
 
Thank you for taking the time to learn more about our treatment options.
 
At Boehringer Ingelheim Mental Health, we are evolving mental health to enable people to thrive.
 
We link behavior to the underlying neurobiology to develop targeted therapies that can ease the burden of these conditions, not just the symptoms.
 
By combining traditional treatments with new and innovative approaches and technologies, we will enable those with mental health conditions such as Schizophrenia or Depression to create more meaningful connections to their lives, loved ones and society.
 
Boehringer Ingelheim has a rich pipeline in all phases of development.
 
 
Visit our websites:
 
 
SC-US-77636 (9/24)
 

   

   

Exhibitor - UT Medical Branch (UTMB) 
 
 
We're glad you stopped by and hope that you aspire to become part of the CMC family. UTMB CMC employs a diverse workforce committed to service, education, community, and innovation.
 
Applicants interested in applying for jobs within Correctional Managed Care should click on http://www.utmb.edu/careers/. Please contact Kevin Martin, Sr. Recruiter/Human Resources - Correctional Managed Care (CMC) at 409-747-2694 or kelmarti@utmb.edu.
 
The future looks promising for UTMB Correctional Managed Care Employees. UTMB Correctional Managed Care is a unique place to operate as a health professional, offering you the opportunity to work in a stimulating, independent and multifaceted workplace. Our healthcare system redevelopment offers valuable and timely experience in innovative care while providing opportunities in clinic management.
 
As a UTMB Correctional Managed Care employee, you are a member of a premier healthcare network that currently includes over 3,100 employees serving 110,000 patients. Not only will you be exposed to a managed care environment, you will be critical to its success. Your efforts will be valued, respected, and recognized.
 
Contact:
Kevin Martin
Sr. Recruiter/Human Resources – Correctional Managed Care (CMC)
1560 W. Bay Area Blvd. Ste. 100 Friendswood, TX 77546
Phone: 409-747-2694  Fax: 409-763-1915  Email: Kelmarti@utmb.edu
University of Texas Medical Branch, 301 University Boulevard, Galveston, Texas  77555-1206
 
 

   

   

Exhibitor - Intracellular Therapies
 

   

   

Exhibitor
 
Exhibitor spots are available for the 2024 Psychiatric Pharmacotherapy Update!
 
If you or someone you know is interested in being an exhibitor, visit our exhibitor website or email mariana.medina@austin.utexas.edu for more information. 
 
 

   

   

Exhibitor
 
Exhibitor spots are available for the 2024 Psychiatric Pharmacotherapy Update!
 
If you or someone you know is interested in being an exhibitor, visit our exhibitor website or email mariana.medina@austin.utexas.edu for more information. 
 
 

   

   

Exhibitor
 
Exhibitor spots are available for the 2024 Psychiatric Pharmacotherapy Update!
 
If you or someone you know is interested in being an exhibitor, visit our exhibitor website or email mariana.medina@austin.utexas.edu for more information. 
 
 

   

   

   

   

   

   

   



System Requirements
Please ensure the computer system you plan to use meets the following minimum requirements:
  • Operating System: Windows 7 or higher, macOS Sierra (10.12) or higher
  • Internet Browser: Chrome 30 or higher, Firefox 27 or higher, Internet Explorer 11, Microsoft Edge, Safari 9 or higher
  • Internet connection: Cable, High-speed DSL, and any other medium that is internet accessible
  • Peripherals: Computer speakers or headphones Media Viewing Requirements: Adobe Reader, HTML5
Education Disclaimer
The author(s) of this continuing education activity have made reasonable efforts to ensure that all information contained herein is accurate in accordance with the latest available scientific evidence at the time of publication. However, because information regarding medications, treatment guidelines, and other healthcare information is subject to constant change, the participant is advised to always confirm practice resources before applying any learned information in practice.Activities produced by UT Continuing Pharmacy Education are intended solely for purposes of supplementing health care professionals’ knowledge. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of The University of Texas at Austin College of Pharmacy.
 
The University of Texas at Austin College of Pharmacy • Continuing Pharmacy Education
2409 University Ave., Stop A1904 | Austin, Texas 78712
Comments to:  UTpharmacyCE@austin.utexas.edu
College of Pharmacy, The University of Texas at Austin
 
LMS Powered By: Learning ExpressCE
Copyright © 2024 University of Texas at Austin College of Pharmacy. All Rights Reserved.
About Us Privacy Policy Terms of Service